Brief: Rovi FY Net Profit At 136.9 Mln Euros

Laboratorios Farmaceuticos Rovi

25/02/2025 06:49

Feb 25 (Reuters) - Laboratorios Farmaceuticos ROVI SA
 ROVI.MC :
    * FY EBITDA 207.4 MILLION EUROS
    * FY REVENUE 763.7 MILLION EUROS
    * FY NET PROFIT 136.9 MILLION EUROS
    * SEES 2025 OPERATING REVENUE TO DECREASE BY
MID-SINGLE-DIGIT
PERCENTAGE VERSUS 2024
    * IS UNABLE TO FORECAST HOW DEMAND AND PRODUCTION MIGHT
EVOLVE FOR
VACCINATION CAMPAIGNS THAT WILL TAKE PLACE IN 2025

Source text:  urn:newsml:reuters.com:*:nCNM1zk3pn
Further company coverage:  ROVI.MC 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))